BiotechTube
Boston Medical Products

Boston Medical Products

Boston, United States· Est.
bosmed.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Boston Medical Products is a niche leader in specialized ENT and respiratory medical devices, holding a unique, defensible position as the exclusive manufacturer of the Montgomery® brand. Its product portfolio, developed in collaboration with physicians, includes silicone airway stents, Safe-T-Tubes, and the STERITALC talc for pleurodesis, which recently gained FDA clearance. As part of the Bess Group, which includes Kurz, the company leverages group synergies to strengthen its international market position and drive innovation in otorhinolaryngology and interventional pulmonology.

Otorhinolaryngology (ENT)PulmonologyOncology Supportive Care

Technology Platform

Proprietary designs in medical-grade silicone for airway stents and laryngeal prostheses; engineered talc particle size for pleurodesis; modular device design for bronchoscopy systems.

Funding History

1
UndisclosedUndisclosed

Opportunities

The recent FDA clearance for STERITALC opens the large US market for pleurodesis, providing a major new growth driver.
Integration with Kurz under the Bess Group umbrella creates significant cross-selling opportunities within the global ENT surgeon customer base.
The redesign of core products and introduction of new systems like NOVATECH modernize the portfolio and can stimulate replacement demand.

Risk Factors

The company faces significant concentration risk due to its heavy reliance on the legacy Montgomery product line.
Growth is constrained by the relatively small, specialized nature of the core ENT surgical device market.
Competition from larger medtech firms with greater R&D resources could threaten market share in airway stents and pleurodesis.

Competitive Landscape

In airway stents, BMP competes with other silicone stent manufacturers (e.g., Hood Laboratories, Bryan Corporation) and companies offering metallic stents. In pleurodesis, STERITALC competes with other talc preparations, iodopovidone, and autologous blood patch procedures. Its monopoly on Montgomery products provides a unique, defensible niche with little direct competition.

More companies in Digital Health & Biotech SaaS →More companies in United States →